Patent directory · USPTO A61K / A61P
Patents matching “The Board of Regents of the University of Texas System”
1,742 pharma patents match "The Board of Regents of the University of Texas System" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,742 pharmaceutical patents matching "The Board of Regents of the University of Texas System" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12121580
Antibacterial photodynamic therapy using copper-cysteamine nanoparticles
granted -
US 12121525
Methods for treating GI syndrome and graft versus host disease
granted -
US 12116604
Transposase polypeptides and uses thereof
granted -
US 12116597
Autophagy as a therapeutic target for intracranial aneurysm
granted -
US 12104181
Compositions and methods for treating viral infections targeting TRIM7
granted -
US 12098138
Substituted pyridinyl azetidinone derivatives for use in treating cancer and other diseases
granted -
US 12097213
Sequential treatment of cancers using 6-thio-dG, checkpoint inhibitors and radiation therapy
granted -
US 12090142
Combination therapy for the treatment of cancer
granted -
US 12091387
Quinoline cGAS antagonist compounds
granted -
US 12091486
Block copolymer and micelle compositions and methods of use thereof
granted -
US 12084403
Linkers for antibody drug conjugates
granted -
US 12077563
Prefusion-stabilized hMPV F proteins
granted -
US 12077540
Substituted 4,6-dihydrospiro[[1,2,3]triazolo[4,5-b]pyridine-7,3'-indoline]-2',5(3H)-dione analogues
granted -
US 12077772
Transgene cassettes, AAV vectors and AAV viral vectors for the expression of human codon-optimized SLC6A1
granted -
US 12077760
DNA aptamers and use thereof for the treatment of cancer
granted -
US 12076328
Pharmaceutical compositions of niclosamide
granted -
US 12070444
Modulation of molecular markers using S-equol
granted -
US 12070443
Methods of treating and preventing breast cancer with S-equol
granted -
US 12070472
Treatment of drug resistant proliferative diseases with telomerase mediated telomere altering compounds
granted -
US 12065416
cGAS antagonist compounds
granted -
US 12064453
Biochemical and biomechanical conditioning for enhancing personalized mesenchymal stem cell therapies
granted -
US 12065490
Chimeric antigen receptors and methods of making
granted -
US 12064413
Methods of treating melanoma with S-equol
granted -
US 12059474
Methods for selecting antibodies that specifically bind glycosylated immune checkpoint proteins
granted